Vicplas International Ltd

Equities

569

SG1G57870584

Medical Equipment, Supplies & Distribution

Market Closed - Singapore S.E. 03:04:49 2024-04-24 am EDT 5-day change 1st Jan Change
0.121 SGD +15.24% Intraday chart for Vicplas International Ltd 0.00% -18.79%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Vicplas International's Fiscal H1 Attributable Profit Slumps on Weak Medical Device Business MT
Vicplas International Ltd Reports Earnings Results for the Half Year Ended January 31, 2024 CI
Vicplas International Ltd Announces the Appointment of Mr. Yeo Kah Chong Mark Andrew as A Non-Executive Independent Director and A Member of the Audit and Risk Committee CI
Vicplas International Ltd Approves Final (One-Tier Tax Exempt) Dividend for the Year Ended July 31, 2023 CI
Vicplas International Leases Purpose Built Facility in Mexico; Shares Jump 5% MT
Vicplas International Ltd Announces Manufacturing Expansion into Mexico CI
Vicplas International Logs Lower Profit, Revenue in Fiscal H2 MT
Vicplas International Ltd Announces Incorporation of A Wholly Owned Subsidiary CI
Vicplas International Ltd Proposes Final (One-Tier Tax Exempt) Dividend for the Financial Year Ended July 31, 2023, Payable on January 22, 2024 CI
Vicplas International Ltd Reports Earnings Results for the Full Year Ended July 31, 2023 CI
Singapore Index Returns to Black; Vicplas Shares Slip 3% as Profit Halves in Fiscal H1 MT
Vicplas International's Profit Halves in Fiscal H1; Shares Slip 7% MT
Vicplas International Ltd Reports Earnings Results for the Half Year Ended January 31, 2023 CI
Vicplas International Ltd Reports Earnings Results for the Half Year Ended January 31, 2023 CI
Vicplas International Ltd. Announces the Retirement of Christopher Paul Lee as Non-Executive Director, Strategy Committee Chairman CI
Vicplas International Ltd Approves Final (One-Tier Tax Exempt) Dividend for the Year Ended July 31, 2022, Payable on January 20, 2023 CI
Singapore Shares End Week in Red; iWOW Technology Shares Climb 4% on Deal to Acquire Singapore Telco MT
Vicplas International's Fiscal H2 Profit Drops 29% Amid Rising Supply Chain Costs; Shares Slip 3% MT
Vicplas International Ltd Proposes Final (One-Tier Tax Exempt) Dividend for the Financial Year Ended July 31, 2022, Payable on January 20, 2023 CI
Vicplas International Ltd Reports Earnings Results for the Full Year Ended July 31, 2022 CI
Vicplas International Ltd Announces Change of Company Secretary, Effective 31 March 2022 CI
Vicplas International's Profit Inches Up in Fiscal H1; Shares Climb 3% MT
Vicplas International Ltd Provides Revenue Guidance for the Year Ending 31 July 2022 CI
Vicplas International Ltd Reports Earnings Results for the Half Year Ended January 31, 2022 CI
Vicplas International Group CEO to Step Down, Replacement Named MT
Chart Vicplas International Ltd
More charts
Vicplas International Ltd is a Singapore-based holding company. The Company operates through two segments: Medical devices and Pipes & pipe fittings. Its Medical devices segment designs, develops and manufactures sterile and non-sterile medical devices. It operates Medical devices segment, through its subsidiaries, Forefront Medical Technology (Pte) Ltd, Forefront Medical Investment Pte. Ltd. and XentiQ (Pte.) Ltd. in Singapore; Forefront (Xiamen) Medical Devices Co., Ltd and Forefront Medical Technology (Jiangsu) Co., Ltd in China; and Arrow Medical Limited in the United Kingdom. Its Pipes & pipe fittings segment manufactures and distributes piping systems for industries, including waste and potable water systems for residential homes, schools, commercial and industrial buildings, and underground electrical systems. It operates Pipes & pipe fittings segment, through its wholly owned subsidiaries, Vicplas Holdings Pte Ltd in Singapore and Rimplas Industries Sdn. Bhd. in Malaysia.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 569 Stock
  4. News Vicplas International Ltd
  5. Vicplas International : ' Fiscal H1 Profit More Than Doubles as Medical Devices Segment Boosts Revenue